These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 22917059

  • 21. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ.
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [Abstract] [Full Text] [Related]

  • 22. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ, Mannoury la Cour C, Chanrion B, Dupuis DS, Di Cara B, Audinot V, Cussac D, Newman-Tancredi A, Kamal M, Boutin JA, Jockers R, Marin P, Bockaert J, Muller O, Dekeyne A, Lavielle G.
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [Abstract] [Full Text] [Related]

  • 23. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat.
    Nair SG, Gudelsky GA.
    Synapse; 2004 Sep 15; 53(4):202-7. PubMed ID: 15266551
    [Abstract] [Full Text] [Related]

  • 24. Elevated cyclic stretch and serotonin result in altered aortic valve remodeling via a mechanosensitive 5-HT(2A) receptor-dependent pathway.
    Balachandran K, Hussain S, Yap CH, Padala M, Chester AH, Yoganathan AP.
    Cardiovasc Pathol; 2012 Sep 15; 21(3):206-13. PubMed ID: 21865058
    [Abstract] [Full Text] [Related]

  • 25. Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus.
    Adams W, van den Buuse M.
    Neuropharmacology; 2011 Sep 15; 61(3):458-67. PubMed ID: 21477601
    [Abstract] [Full Text] [Related]

  • 26. 5-HT2C receptor modulators: a patent survey.
    Lee J, Jung ME, Lee J.
    Expert Opin Ther Pat; 2010 Nov 15; 20(11):1429-55. PubMed ID: 20849206
    [Abstract] [Full Text] [Related]

  • 27. Serotonin control of sleep-wake behavior.
    Monti JM.
    Sleep Med Rev; 2011 Aug 15; 15(4):269-81. PubMed ID: 21459634
    [Abstract] [Full Text] [Related]

  • 28. Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system.
    Murotani T, Ishizuka T, Isogawa Y, Karashima M, Yamatodani A.
    Neuropharmacology; 2011 Aug 15; 61(1-2):228-33. PubMed ID: 21514311
    [Abstract] [Full Text] [Related]

  • 29. Serotonin in the pathophysiology and treatment of CNS disorders.
    Di Giovanni G.
    Exp Brain Res; 2013 Oct 15; 230(4):371-3. PubMed ID: 24057054
    [No Abstract] [Full Text] [Related]

  • 30. The role of serotonin receptor subtypes in treating depression: a review of animal studies.
    Carr GV, Lucki I.
    Psychopharmacology (Berl); 2011 Feb 15; 213(2-3):265-87. PubMed ID: 21107537
    [Abstract] [Full Text] [Related]

  • 31. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK, Byerley WF, McCabe RT, McConnell EJ, Dawson TM, Grosser BI.
    J Clin Psychiatry; 1987 Mar 15; 48 Suppl():19-25. PubMed ID: 3029045
    [Abstract] [Full Text] [Related]

  • 32. [Possible role of serotonin 5-HT2 receptors in mechanism of afobazole anxiolytic action: neurochemical study of inter-line differences in mice].
    Raevskiĭ KS, Narkevich VB, Klodt PM, Kudrin VS.
    Eksp Klin Farmakol; 2011 Mar 15; 74(12):3-7. PubMed ID: 22379873
    [Abstract] [Full Text] [Related]

  • 33. Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement.
    Fletcher PJ, Sinyard J, Higgins GA.
    Pharmacol Biochem Behav; 2010 Nov 15; 97(1):170-8. PubMed ID: 20624416
    [Abstract] [Full Text] [Related]

  • 34. Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.
    Samuels BA, Mendez-David I, Faye C, David SA, Pierz KA, Gardier AM, Hen R, David DJ.
    Neuroscientist; 2016 Feb 15; 22(1):26-45. PubMed ID: 25488850
    [Abstract] [Full Text] [Related]

  • 35. Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs.
    Martin CB, Hamon M, Lanfumey L, Mongeau R.
    Neurosci Biobehav Rev; 2014 May 15; 42():208-23. PubMed ID: 24631644
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT2A Antagonist Activity for the Treatment of Depression.
    Xu X, Wei Y, Guo Q, Zhao S, Liu Z, Xiao T, Liu Y, Qiu Y, Hou Y, Zhang G, Wang K.
    J Pharmacol Exp Ther; 2018 Jun 15; 365(3):624-635. PubMed ID: 29615471
    [Abstract] [Full Text] [Related]

  • 37. 5-HT2 receptors.
    Leysen JE.
    Curr Drug Targets CNS Neurol Disord; 2004 Feb 15; 3(1):11-26. PubMed ID: 14965241
    [Abstract] [Full Text] [Related]

  • 38. Role of 5-HT2 receptors in diabetes: Swertiamarin seco-iridoid glycoside might be a possible 5-HT2 receptor modulator.
    Sonawane RD, Deore VB, Patil SD, Patil CR, Surana SJ, Goyal RK.
    Physiol Behav; 2015 May 15; 144():66-72. PubMed ID: 25708274
    [Abstract] [Full Text] [Related]

  • 39. New approaches to the pharmacological management of generalized anxiety disorder.
    Buoli M, Caldiroli A, Caletti E, Paoli RA, Altamura AC.
    Expert Opin Pharmacother; 2013 Feb 15; 14(2):175-84. PubMed ID: 23282069
    [Abstract] [Full Text] [Related]

  • 40. [Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives].
    Javelot H.
    Ann Pharm Fr; 2016 Mar 15; 74(2):93-118. PubMed ID: 26472602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.